{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:31:01Z","timestamp":1791322261243,"version":"4.3.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Valeant Pharmaceuticals North America LLC, Bridgewater, NJ"},{"name":"Valeant Pharmaceuticals North America LLC"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.jaad.2012.10.013","type":"journal-article","created":{"date-parts":[[2012,11,20]],"date-time":"2012-11-20T07:01:00Z","timestamp":1353394860000},"page":"600-608","source":"Crossref","is-referenced-by-count":201,"title":["Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies"],"prefix":"10.1016","volume":"68","author":[{"given":"Boni E.","family":"Elewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phoebe","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Pollak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Pariser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisato","family":"Senda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikara","family":"Ieda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhakrishnan","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tage","family":"Ramakrishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason T.","family":"Olin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2012.10.013_bib1","first-page":"11","article-title":"Advances in the diagnosis and treatment of onychomycosis","volume":"34","author":"Scher","year":"1998","journal-title":"Hosp Med"},{"key":"10.1016\/j.jaad.2012.10.013_bib2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3810\/pgm.1998.02.359","article-title":"Common dermatophyte infections: a simple diagnostic test and current management","volume":"103","author":"Crissey","year":"1998","journal-title":"Postgrad Med"},{"key":"10.1016\/j.jaad.2012.10.013_bib3","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1517\/13543780902810352","article-title":"New antifungal therapies for the treatment of onychomycosis","volume":"18","author":"Kumar","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"issue":"Suppl","key":"10.1016\/j.jaad.2012.10.013_bib4","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S0190-9622(99)70397-X","article-title":"Onychomycosis: therapeutic update","volume":"40","author":"Scher","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2012.10.013_bib5","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/archderm.1997.03890450124022","article-title":"Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions","volume":"133","author":"Elewski","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2012.10.013_bib6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0190-9622(99)70047-2","article-title":"The impact of onychomycosis on quality of life: development of\u00a0an international onychomycosis questionnaire to measure patient quality of life","volume":"41","author":"Drake","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2012.10.013_bib7","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0190-9622(96)90061-4","article-title":"Onychomycosis: a significant medical disorder","volume":"35","author":"Scher","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2012.10.013_bib8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF00449429","article-title":"Quality of life of persons with onychomycosis","volume":"2","author":"Lubeck","year":"1993","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jaad.2012.10.013_bib9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2230.1997.tb02626.x","article-title":"The impact of onychomycosis on quality of life","volume":"22","author":"Whittam","year":"1997","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2012.10.013_bib10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2165\/11592120-000000000-00000","article-title":"Health-related quality of life in patients with nail disorders","volume":"12","author":"Reich","year":"2011","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2012.10.013_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1529-8019.2007.00109.x","article-title":"Toenail onychomycosis: current and future treatment options","volume":"20","author":"Finch","year":"2007","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2012.10.013_bib12","series-title":"Sporanox (itraconazole) [package insert]","year":"2012"},{"key":"10.1016\/j.jaad.2012.10.013_bib13","series-title":"Lamisil (terbinafine HCl) [package insert]","year":"2012"},{"key":"10.1016\/j.jaad.2012.10.013_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjopharm.2005.12.012","article-title":"Safety and efficacy of oral\u00a0terbinafine in the treatment of onychomycosis: analysis of\u00a0the elderly subgroup in improving results in onychomycosis-concomitant Lamisil and debridement (IRON-CLAD), an open-label, randomized trial","volume":"4","author":"Tavakkol","year":"2006","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.jaad.2012.10.013_bib15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000073086","article-title":"Treatment failures and relapses in onychomycosis: a stubborn clinical problem","volume":"207","author":"Arrese","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2012.10.013_bib16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/00128071-200304010-00005","article-title":"Terbinafine: a review of its use in onychomycosis in adults","volume":"4","author":"Darkes","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2012.10.013_bib17","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jaad.2005.04.055","article-title":"Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial","volume":"53","author":"Warshaw","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2012.10.013_bib18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2133.2007.07974.x","volume":"157","author":"Baran","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2012.10.013_bib19","first-page":"26","article-title":"Fungal nail infections: diagnosis and management [editorial]","volume":"18","year":"2009","journal-title":"Prescrire Int"},{"key":"10.1016\/j.jaad.2012.10.013_bib20","doi-asserted-by":"crossref","first-page":"495","DOI":"10.7547\/87507315-90-10-495","article-title":"Ciclopirox 8% nail lacquer in the treatment of onychomycosis of the toenails in the United States","volume":"90","author":"Gupta","year":"2000","journal-title":"J Am Podiatr Med Assoc"},{"key":"10.1016\/j.jaad.2012.10.013_bib21","first-page":"5","article-title":"Physical and microbiological properties of a new nail protective medical device","volume":"4","author":"Sparavigna","year":"2008","journal-title":"J Plastic Dermatol"},{"key":"10.1016\/j.jaad.2012.10.013_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1468-3083.2004.00988.x","article-title":"Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy","volume":"19","author":"Baran","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2012.10.013_bib23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1468-3083.2005.01284.x","article-title":"Treatment options\u2013development of consensus guidelines","volume":"19","author":"Lecha","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2012.10.013_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(01)00989-9","article-title":"Drug delivery to the nail following topical application","volume":"236","author":"Murdan","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jaad.2012.10.013_bib25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0065-7743(05)40021-4","article-title":"Progress on new therapeutics for fungal nail infections","volume":"40","author":"Baker","year":"2005","journal-title":"Ann Rep Med Chem"},{"key":"10.1016\/j.jaad.2012.10.013_bib26","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.2042-7158.1997.tb06747.x","article-title":"In\u00a0vitro permeability of the human nail and of a keratin membrane from bovine hooves: influence of the partition coefficient octanol\/water and the water solubility of drugs on their permeability and maximum flux","volume":"49","author":"Mertin","year":"1997","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.jaad.2012.10.013_bib27","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ejps.2003.11.008","article-title":"In\u00a0vitro permeation of several drugs through the human plate: relationship between physicochemical properties and nail permeability of drugs","volume":"21","author":"Kobayashi","year":"2004","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.jaad.2012.10.013_bib28","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1128\/AAC.46.12.3797-3801.2002","article-title":"Therapeutic efficacy of topically applied KP-103 against experimental tinea unguium in guinea pigs in comparison with amorolfine and terbinafine","volume":"46","author":"Tatsumi","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jaad.2012.10.013_bib29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2165\/00128071-200405030-00002","article-title":"Assessing treatment outcomes in toenail onychomycosis clinical trials","volume":"5","author":"Werschler","year":"2004","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2012.10.013_bib30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1365-2133.1999.00009.x","article-title":"Long-term outcomes in the treatment of toenail onychomycosis","volume":"141","author":"De Cuyper","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2012.10.013_bib31","doi-asserted-by":"crossref","unstructured":"Elewski BE, Ghannoum MA, Mayser P, Gupta AK, Korting HC, Shouey RJ, et\u00a0al. Efficacy, safety and tolerability of topical terbinafine nail solution in patients with mild-to-moderate toenail onychomycosis: results from three randomized studies\u00a0using double-blind vehicle-controlled and open-label active-controlled designs. J Eur Acad Dermatol Venereol December doi: 10.1111\/j.1468-3083.2011.04373.x. Published online December 20, 2011.","DOI":"10.1111\/j.1468-3083.2011.04373.x"},{"key":"10.1016\/j.jaad.2012.10.013_bib32","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaad.2009.04.062","article-title":"Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents","volume":"62","author":"Piraccini","year":"2010","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962212011401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962212011401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,14]],"date-time":"2018-07-14T07:41:17Z","timestamp":1531554077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962212011401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0190962212011401"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2012.10.013","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717969209.793468567","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717969209.793561575","asserted-by":"object"}]},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}